Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
Gain Therapeutics, Inc.
Filing: 10-K
Filed On: 2024-03-26
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
10-K
10-K
EX-4.1
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
EX-23.1
Consents of experts and counsel
EX-31.1
Management Certification of annual or quarter disclosure
EX-31.2
Management Certification of annual or quarter disclosure
EX-32.1
Section 1350 Certifications
EX-97.1
ganx-20231231xex97d1.htm
GRAPHIC
ganx-20231231x10k001.jpg
GRAPHIC
ganx-20231231x10k002.jpg
GRAPHIC
ganx-20231231x10k003.jpg
GRAPHIC
ganx-20231231x10k004.jpg
GRAPHIC
ganx-20231231x10k005.jpg
GRAPHIC
ganx-20231231x10k006.jpg
GRAPHIC
ganx-20231231x10k007.jpg
0001558370-24-003943.txt
Data files
EX-101.SCH
ganx-20231231.xsd
EX-101.CAL
ganx-20231231_cal.xml
EX-101.DEF
ganx-20231231_def.xml
EX-101.LAB
ganx-20231231_lab.xml
EX-101.PRE
ganx-20231231_pre.xml
XML
ganx-20231231x10k_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.